市場調查報告書

單株抗體(MAbS)的全球市場:2020年

Monoclonal Antibodies (MAbS) Global Market Report 2020

出版商 The Business Research Company 商品編碼 918120
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
單株抗體(MAbS)的全球市場:2020年 Monoclonal Antibodies (MAbS) Global Market Report 2020
出版日期: 2019年12月09日內容資訊: 英文
簡介

本報告提供全球單株抗體(MABS)市場的相關調查,市場趨勢及策略,市場成長及阻礙因素,各類型、用途、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 市場特徵

第3章 市場規模及成長

  • 過去的市場
  • 市場預測
    • 市場成長要素
    • 市場阻礙因素

第4章 市場區隔

  • 各原料:過去/預測
    • 嵌合體
    • 人體化
  • 各用途:過去/預測
    • 抗癌劑
    • 免疫學的
    • 抗感染性單株抗體(MAbs)
    • 神經藥理學
    • 心血管、腦血管
    • 其他
  • 各終端用戶:過去/預測
    • 醫院
    • 私人診所
    • 研究所

第5章 市場分析:各地區/國家

  • 市場過去/預測:各地區
  • 市場過去/預測:各國

第6章 亞太地區市場

  • 市場概要
  • 各原料:過去/預測
  • 各用途:過去/預測
  • 各終端用戶:過去/預測

第7章 中國市場

第8章 印度市場

第9章 日本市場

第10章 澳洲市場

第11章 印尼市場

第12章 韓國市場

第13章 西歐市場

第14章 英國市場

第15章 德國市場

第16章 法國市場

第17章 東歐市場

第18章 俄羅斯市場

第19章 北美市場

第20章 美國市場

第21章 南美市場

第22章 巴西市場

第23章 中東市場

第24章 非洲市場

第25章 競爭情形及企業簡介

  • 競爭情形
  • 企業簡介
    • Johnson & Johnson
    • Merck
    • AbbVie
    • Amgen
    • Glaxosmithkline plc

第26章 主要合併及收購

第27章 市場趨勢及策略

第28章 產品平台分析

第29章 市場今後的預測及潛在力分析

第30章 附錄

  • 簡稱
  • 貨幣
  • 調查相關諮詢方式
  • 商務調查企業
  • 著作權及免責聲明
目錄

Monoclonal Antibodies (MAbS) Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global monoclonal antibodies (mabs) market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the monoclonal antibodies (mabs)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Monoclonal Antibodies (MAbS) Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

Markets Covered: 1) By Source: Murine, Chimeric, Humanized, Human 2) By Application: Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies (MAbs), Neuropharmacological, Cardiovascular And Cerebrovascular, Others 3) By End Users: Hospitals, Private Clinics, Research Institute

Companies Mentioned: Johnson & Johnson, Merck, AbbVie, Amgen, Glaxosmithkline plc

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Five years historic and forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Monoclonal Antibodies Market Characteristics

3. Monoclonal Antibodies Market Size And Growth

  • 3.1. Global Monoclonal Antibodies Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Monoclonal Antibodies Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Monoclonal Antibodies Market Segmentation

  • 4.1. Global Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Murine
    • Chimeric
    • Humanized
    • Human
  • 4.2. Global Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Anti-Cancer
    • Immunological
    • Anti-Infective Monoclonal Antibodies (MAbs)
    • Neuropharmacological
    • Cardiovascular And Cerebrovascular
    • Others
  • 4.3. Global Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Hospitals
    • Private Clinics
    • Research Institute

5. Monoclonal Antibodies Market Regional And Country Analysis

  • 5.1. Global Monoclonal Antibodies Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 5.2. Global Monoclonal Antibodies Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Monoclonal Antibodies Market

  • 6.1. Asia-Pacific Monoclonal Antibodies Market Overview
  • 6.2. Asia-Pacific Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 6.4. Asia-Pacific Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Monoclonal Antibodies Market

  • 7.1. China Monoclonal Antibodies Market Overview
  • 7.2. China Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
  • 7.3. China Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
  • 7.4. China Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Monoclonal Antibodies Market

  • 8.1. India Monoclonal Antibodies Market Overview
  • 8.2. India Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 8.3. India Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 8.4. India Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Monoclonal Antibodies Market

  • 9.1. Japan Monoclonal Antibodies Market Overview
  • 9.2. Japan Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 9.3. Japan Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 9.4. Japan Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Monoclonal Antibodies Market

  • 10.1. Australia Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 10.2. Australia Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 10.3. Australia Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Monoclonal Antibodies Market

  • 11.1. Indonesia Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 11.3. Indonesia Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Monoclonal Antibodies Market

  • 12.1. South Korea Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 12.3. South Korea Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Monoclonal Antibodies Market

  • 13.1. Western Europe Monoclonal Antibodies Market Overview
  • 13.2. Western Europe Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 13.4. Western Europe Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Monoclonal Antibodies Market

  • 14.1. UK Monoclonal Antibodies Market Overview
  • 14.2. UK Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 14.3. UK Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 14.4. UK Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Monoclonal Antibodies Market

  • 15.1. Germany Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 15.2. Germany Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 15.3. Germany Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Monoclonal Antibodies Market

  • 16.5. France Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 16.6. France Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 16.7. France Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Monoclonal Antibodies Market

  • 17.1. Eastern Europe Monoclonal Antibodies Market Overview
  • 17.2. Eastern Europe Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 17.4. Eastern Europe Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Monoclonal Antibodies Market

  • 18.1. Russia Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 18.2. Russia Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 18.3. Russia Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Monoclonal Antibodies Market

  • 19.1. North America Monoclonal Antibodies Market Overview
  • 19.2. North America Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 19.3. North America Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 19.4. North America Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Monoclonal Antibodies Market

  • 20.1. USA Monoclonal Antibodies Market Overview
  • 20.2. USA Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 20.3. USA Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 20.4. USA Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Monoclonal Antibodies Market

  • 21.1. South America Monoclonal Antibodies Market Overview
  • 21.2. South America Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 21.3. South America Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 21.4. South America Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Monoclonal Antibodies Market

  • 22.1. Brazil Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 22.3. Brazil Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Monoclonal Antibodies Market

  • 23.1. Middle East Monoclonal Antibodies Market Overview
  • 23.2. Middle East Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 23.4. Middle East Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Monoclonal Antibodies Market

  • 24.1. Africa Monoclonal Antibodies Market Overview
  • 24.2. Africa Monoclonal Antibodies Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 24.3. Africa Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 24.4. Africa Monoclonal Antibodies Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Monoclonal Antibodies Market Competitive Landscape And Company Profiles

  • 25.1. Monoclonal Antibodies Market Competitive Landscape
  • 25.2. Monoclonal Antibodies Market Company Profiles
    • 25.2.1. Johnson & Johnson
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Merck
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. AbbVie
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Amgen
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Glaxosmithkline plc
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Monoclonal Antibodies Market

27. Monoclonal Antibodies Market Trends And Strategies

28. Product Pipeline Analysis

29. Monoclonal Antibodies Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer
Back to Top